Hem
What it's like to trial Elon Musk's brain chip

Förlamade Sebastian har ett chip i hjärnan: ”Magiskt”

Sebastian Gomez-Pena har fått ett chip från Neuralink inopererat i hjärnan och tycker att det ”känns magiskt”.

– Den här typen av teknologi ger nytt hopp, säger han till Sky News.

Gomez-Pena är förlamad från halsen och ner efter en olycka. Han är en av de första personerna i Storbritannien som har fått hjärnimplantatet, som varit under utveckling i uppåt 20 år.

Information överförs trådlöst från chippet till en dator där AI tolkar signalerna och översätter Gomez-Penas instruktioner till en muspekare på hans dator eller telefon.

– Du bara tänker tanken och så händer det.

Studien på människor, där Gomez-Pena är en av sju deltagare, är fortfarande i ett tidigt skede och har inte genomgått referentgranskning eller publicerats i någon vetenskaplig tidskrift.

bakgrund
 
Neuralink
Wikipedia (en)
Neuralink Corp. is an American neurotechnology company that has developed as of 2024 implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers. Neuralink was launched in 2016 and first publicly reported in March 2017. The company is based in Fremont, California, with plans to build a three-story building with office and manufacturing space in Del Valle, about 10 miles east of Gigafactory Texas, Tesla's headquarters and manufacturing plant. Since its founding, the company has hired several high-profile neuroscientists from various universities. By 2019, it had received $158 million in funding ($100 million was from Musk) and had 90 employees. At that time, Neuralink announced that it was working on a "sewing machine-like" device capable of implanting very thin (4 to 6 μm in width) threads into the brain, and demonstrated a system that reads information from a lab rat via 1,500 electrodes. It anticipated starting experiments with humans in 2020, but later moved that to 2023. As of May 2023, it has been approved for human trials in the United States. On January 29, 2024, Musk announced that Neuralink had successfully implanted a Neuralink device in a human and that the patient was recovering. He was later identified as Noland Arbaugh. The company has faced criticism for the large number of primates that were euthanized after medical trials. The monkeys' veterinary records allegedly show complications with surgically implanted electrodes. In September 2024, Neuralink announced that its latest development effort, Blindsight, would enable blind people whose visual cortex is undamaged to regain some level of vision. The development received "breakthrough" status from the U.S. federal government, which will accelerate development. In August and September 2025, Toronto's University Health Network performed Canada's first Neuralink brain implant surgeries on two patients with cervical spinal cord injuries, marking the first such procedures outside the United States.
Omni är politiskt obundna och oberoende. Vi strävar efter att ge fler perspektiv på nyheterna. Har du frågor eller synpunkter kring vår rapportering? Kontakta redaktionen